eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cystic fibrosis |
| Symptom | C0876973|pulmonary infections |
| Sentences | 14 |
| PubMedID- 26356298 | A group of 17 closely related species, designated b. cepacia complex organisms, cause pulmonary infections primarily in patients with cystic fibrosis . |
| PubMedID- 23943728 | Background: the paranasal sinuses can be a bacterial reservoir for pulmonary infections in patients with cystic fibrosis (cf) methodology: in this prospective, non-randomised, uncontrolled, intervention cohort study, the clinical effect of sinus surgery followed by two weeks` intravenous antibiotics, 6 months` antibiotic nasal irrigations was assessed in 106 cf patients. |
| PubMedID- 25717335 | Burkholderia scvs are associated with worse patient prognoses during pulmonary infections of persons with cystic fibrosis (cf) (haussler et al., 2003; silva et al., 2011), and correlate with higher biofilm productivity in our laboratory model (poltak and cooper, 2011). |
| PubMedID- 24201191 | Mycobacterium abscessus is a rapidly growing mycobacterium and an emerging human pathogen causing pulmonary infections, especially in patients with cystic fibrosis and other underlying lung disorders (1). |
| PubMedID- 25741986 | Background: the antibiotics used to treat pulmonary infections in people with cystic fibrosis are typically chosen based on the results of antimicrobial susceptibility testing performed on bacteria traditionally grown in a planktonic mode (grown in a liquid). |
| PubMedID- 23382856 | Background: the genus burkholderia includes pathogenic gram-negative bacteria that cause melioidosis, glanders, and pulmonary infections of patients with cancer and cystic fibrosis. |
| PubMedID- 20093293 | Pseudomonas aeruginosa is the major aetiological agent of chronic pulmonary infections in patients with cystic fibrosis (cf). |
| PubMedID- 24637508 | Aeruginosa is an opportunistic bacterial pathogen which establishes chronic pulmonary infections in patients with cystic fibrosis (cf). |
| PubMedID- 21428129 | Health care utilization & costs for cystic fibrosis patients with pulmonary infections. |
| PubMedID- 19805554 | The results of the study show that the high concentrations of levofloxacin readily achievable in the lung following aerosol delivery may be useful for the management of pulmonary infections in patients with cystic fibrosis. |
| PubMedID- 26187366 | Burkholderia cenocepacia and other members of the burkholderia cepacia complex (bcc) are highly multidrug-resistant bacteria that cause severe pulmonary infections in patients with cystic fibrosis. |
| PubMedID- 20625718 | Aeruginosa even in mature biofilms and cationic steroid antibiotics can thus be considered as potential candidates for the treatment of chronic pulmonary infections of patients with cystic fibrosis. |
| PubMedID- 22150831 | Burkholderia cepacia complex (bcc) bacteria are opportunistic pathogens that cause multiresistant pulmonary infections in patients with cystic fibrosis (cf). |
| PubMedID- 24671511 | Scientific reports suggest p. aeruginosa as the most important pathogen and causal agent of chronic pulmonary infections in patients with cystic fibrosis, which leads to gradual and eventually fatal decline in pulmonary function (govan and deretic 1996). |
Page: 1